Adenocarcinoma of the stomach and neuroendocrine carcinoma of the colon in a 45-year-old male patient suffering from common variable immunodeficiency (CVID) and ulcerative colitis;Adenokarzinom des Magens und neuroendokrines Kolonkarzinom bei einem 45-jährigen Patienten mit Common Variable Immunodeficiency (CVID) und Colitis ulcerosa

Zeitschrift fur Gastroenterologie

Volumn 50, Issue 12, 2012, Pages 1292-1295

  Gemeinhardt, M ^a   Turck J ^a   Piper, B ^a   Helmberger, T ^b   Nerlich, A ^a   Schepp, W ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b KLINIKUM BOGENHAUSEN   (Germany)

Author keywords

common variable immunodeficiency (CVID); gastric cancer; neuroendocrine colorectal carcinoma; ulcerative colitis

Indexed keywords

ADULT; ARTICLE; CANCER DIAGNOSIS; CASE REPORT; COLORECTAL CARCINOMA; COLORECTUM NEUROENDOCRINE CARINOMA; COMMON VARIABLE IMMUNODEFICIENCY; DISEASE ASSOCIATION; GASTRECTOMY; HUMAN; MALE; NEUROENDOCRINE TUMOR; PROCTOCOLECTOMY; STOMACH ADENOCARCINOMA; ULCERATIVE COLITIS; WEIGHT REDUCTION;

ADENOCARCINOMA; COLITIS, ULCERATIVE; COLONIC NEOPLASMS; COMMON VARIABLE IMMUNODEFICIENCY; DIAGNOSIS, DIFFERENTIAL; HUMANS; MALE; MIDDLE AGED; NEOPLASMS, MULTIPLE PRIMARY; NEUROENDOCRINE TUMORS; PRECANCEROUS CONDITIONS; STOMACH NEOPLASMS;

EID: 84870424102     PISSN: 00442771     EISSN: 14397803     Source Type: Journal    
DOI: 10.1055/s-0032-1313181     Document Type: Article

References (24)

1. Moehler M., Al-Batran S. E., Andus T. et al. S3-Leitlinie Magenkarzinom - Diagnostik und Therapie der Adenokarzinome des Magens und ösophagealen Übergangs. Z Gastroenterol: 2011; 49 461 531
2. Ahlman H., Nilsson O., McNicol A. M. et al. Poorly-differentiated neuroendocrine carcinomas of midgut and hindgut origin. Neuroendocrinology: 2008; 87 40 46 (Pubitemid 350308293)
3. Öberg K., Akerström G., Rindi G. et al. Neuroendocrine gastroenteropancreatic tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol: 2010; 21 05 v223 v227
4. Ahn S., Mayer L., Cunningham-Rundles C. Clinical manifestations and epidemiology of common variable immunodeficiency. Uptodate: 2011
5. Cunningham-Rundles C. How I treat CVID. Blood: 2010; 116 7 15
6. Resnick E. S., Moshier E. L., Godbold J. H. et al. Morbidity and Mortality in common variable immunodeficiency over 4 decades. Blood: 2012; 119 1650 1657
7. Vorechovsky I., Cullen M., Carrington M. et al. Fine mapping of IGAD1 in IgA deficiency and CVID: indentification and characterization of haplotypes shared by affected members of 101 multiple-case families. J Immunol: 2000; 164 4408 4416 (Pubitemid 30215105)
8. Knight A. K., Radigan L., Marron T. et al. High serum levels of BAFF, APRIL and TACI in common variable immunodeficiency. Clin Immunol: 2007; 124 182 189 (Pubitemid 47059040)
9. Malamut G., Verkarre V., Suarez F. et al. The enteropathy associated with CVID: The delineated frontiers with celiac disease. Am J Gastroenterol: 2010; 105 2262 2275
10. Agarwal S., Smereka P., Harpaz N. et al. Characterization of immunologic defects in patients with CVID with intestinal disease. Inflamm Bowel Dis: 2011; 17 251 259
11. Agarwal S., Mayer L. Gastrointestinal manifestations in primary immune disorders. Inflamm Bowel Dis: 2010; 16 703 711
12. Daniels J. A., Lederman H. M., Maitra A. et al. Gastrointestinal tract pathology in patients with common variable immunodeficiency (CVID): A clinicopathologic study and review. Am J Surg Path: 2007; 31 1800 1812 (Pubitemid 350175807)
13. Busse P. J., Razvi S., Cunningham-Rundles C. Efficacy of intravenous immunoglobulin in the prevention of pneumonia in patients with CVID. J Allergy Clin Immunol: 2002; 109 1001 1004 (Pubitemid 34634312)
14. Ahn S., Mayer L., Cunningham-Rundles C. Treatment and prognosis of CVID. Uptodate: 2011
15. Chua I., Standish R., Lear S. et al. Anti-tumornecrosis-factor-alpha therapy for severe enteropathy in patients with CVID. Clin Exp Immunol: 2007; 150 306 311 (Pubitemid 47609561)
16. Mellemkjaer L., Hammarstrom L., Andersen V. et al. Cancer risk among patients with IgA deficiency or CVID and their relatives: a combined Danish and Swedish study. Clin Exp Immunol: 2002; 130 495 500 (Pubitemid 35418334)
17. Kinlen L., Webster A. DB, Bird A. G. et al. Prospective study of cancer in patients with hypogammaglobulinemia. Lancet: 1985; 1 263 265
18. Desar I. ME, van Deuren M., Sprong T. et al. Serum bactericidal activity against Helicobacter pylori in patients with hypogammaglobulinaemia. Clin Exp Immunol: 2009; 156 434 439
19. Dhalla F., da Silva S. P., Lucas M. et al. Review of gastric cancer risk factors in patients with cvid disorders, resulting in a proposal for a surveillance programme. Clin Exp Immunol: 2011; 165 1 7
20. Zullo A., Romiti A., Rinaldi V. et al. Gastric pathology in patients with CVID. Gut: 1999; 45 77 81
21. Dignass A., Preiss J. C., Aust D. E. et al. Updated German guideline on diagnosis and treatment of ulcerative colitis. Z Gastroenterol: 2011; 49 1276 341
22. Grassia R., Bodini P., Dizioli P. et al. Neuroendocrine carcinomas arising in ulcerative colitis: coincidence or possible correlations? World J Gastroenterol: 2009; 33 4193 4195
23. Sigel J. E., Goldblum J. R. Neuroendocrine neoplasms arising in inflammatory bowel disease: a report of 14 cases. Mod Pathol: 1998; 92 537 542 (Pubitemid 28280717)
24. Conley M. E., Notarangelo L. D., Etzioni A. Diagnostic criteria for primary immunodeficiencies. Representing PAGID and ESID. Clin Immunol: 1999; 93 190